Optimark (gadoversetamide Injection) – Association With Nephrogenic Systemic Fibrosis (nsf) In Patients With Renal Impairment – For The Public

Reason
Product safety
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2010-01-12
Status
Closed
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/edd6f370-a7c0-4ff3-8099-d41cd65e3bee